期刊文献+

甲状腺髓样癌诊断的研究进展 被引量:3

下载PDF
导出
摘要 甲状腺髓样癌起源于甲状腺滤泡旁C细胞,约占甲状腺癌总数的3.0%-10.0%,但死亡率却高达甲状腺癌的13.4%[1]。加之MTC早期即可侵犯区域淋巴结,病程中易向肺、骨、肝等远处器官转移,故预后相对较差。因此,MTC的早期诊断对于改善患者预后具有极其重要的意义。但由于其起病较为隐匿,且患者早期常无自觉症状。
出处 《中国实验诊断学》 2014年第11期1902-1904,共3页 Chinese Journal of Laboratory Diagnosis
  • 相关文献

参考文献5

二级参考文献67

  • 1王利,刘文玉,周桂芝.癌胚抗原在诊断肠癌及其他肿瘤中的应用[J].白求恩军医学院学报,2007,5(2):115-116. 被引量:4
  • 2Liu J,Singh B,Tallini G,et al.Follicular variant of papillary thyroid carcinoma:a clinicopathologic study of a problematic entity[J].Cancer,2006,107(6):1255-1264.
  • 3Brauckhoff M,Lorenz K,Ukkat J,et al.Medullary thyroid carcinoma[J].Scand J Surg,2004,93(4):249-260.
  • 4Lee T I,Yang H J,Lin S Y,et al.The accuracy of fi ne-needle aspiration biopsy and frozen section in patients with thyroid cancer[J].Thyroid,2002,12(7):619-626.
  • 5Baloch Z W,Fleisher S,LiVolsi V A,et al.Diagnosis of"follicular neoplasm":a gray zone in thyroid fine-needle aspiration cytology[J].Diagn Cytopathol,2002,26(1):41-44.
  • 6Alaedeen D I,Khiyami A,McHenry C R.Fine-needle aspiration biopsy specimen with a predominance of Hurthle ceils:a dilemma in the management of nodular thyroid disease[J].Surgery,2005,138(4):650-656.
  • 7Laco J,Ryska A,Cáp J,Celakovsky P.Expression of galectin-3,cytokeratin 19,neural cell adhesion molecule and Ecadhedrin in certain variants of papillary thyroid carcinoma[J].Cesk Patol,2008,44(4):103-107.
  • 8Semenov DIu,Pozharisskil K M,Boriskova M E,et al.Galectin-3 in diagnosis of thyroid cancer[J].Vopr Onkol,2008,54(3):321-323.
  • 9Than T H,Swethadri G K,Wong J,et al.Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators[J].Singapore Med J,2008,49(4):333-338.
  • 10Kopezynska E,Kwapisz J,Junik R,Tyrakowski T.Cellular tumor markers in thyroid cancer[J].Pol Merkur Lekarski,2007,22(130):295-299.

共引文献44

同被引文献40

  • 1柴红,陈泽泉,余永利.甲状腺髓样癌靶向治疗新进展[J].上海交通大学学报(医学版),2011,31(10):1470-1474. 被引量:3
  • 2罗葆明,曾婕,欧冰,智慧.乳腺超声弹性成像检查感兴趣区域大小对诊断结果影响[J].中国医学影像技术,2007,23(9):1330-1332. 被引量:139
  • 3郝儒田,张筱骅,潘贻飞.甲状腺乳头状癌与甲状腺结节钙化的关系探讨[J].中国肿瘤临床,2007,34(20):1178-1180. 被引量:56
  • 4陆凡倩,陈晓红.甲状腺髓样癌治疗进展.国际耳鼻咽喉头颈外科杂志,2015,39:46-51.
  • 5Samulski TD, Livolsi VA, Montone K, et al. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma : An institutional experience. Pathol Res Pract, 2014, 210: 182-185.
  • 6Andrioli M, Trimboli P, Amendola S, et al. Elastographic presentation of medullary thyroid carcinoma. Endocrine, 2014, 45: 153-155.
  • 7Alevizaki M, Kyratzoglou E, Bamias A, et al. Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literature. Endocrine, 2013, 44: 610-615.
  • 8Qi xP, Zhao JQ, Du ZF, et al. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China. Eur J SurgOncol., 2013, 39: 1007-1012.
  • 9Meijer JA, Bakker LE, Valk GD, et al. Radioactive iodine in the treatment of medullary thyroid carcinoma : A controlled multicenter study. EurJEndocrinol, 2013, 168: 779-786.
  • 10蓝伟桐.分化型甲状腺癌的诊断[J].中国实用医药,2009,4(18):29-30. 被引量:1

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部